CRI market research report

Protein Engineering Market Forecast till 2027

$4450 – $6250

Protein Engineering Market: Information by Type (Instrument, Reagent, Services & Software), by Application (Food & Detergent Industries, Environmental, Medical, Biopolymer Production, Nano Biotechnology), by Method (Rational Protein Design and Directed Evolution), by End User (Pharmaceuticals & Biotechnology Companies, Contract Engineering Organizations, Academic Research Institutes), and Region (Americas, Europe, Asia-Pacific, and Middle East & Africa)—Forecast till 2027

SKU: MRFR210239 Category: Tag:

Description

Protein Engineering Market Forecast till 2027

Protein Engineering Market overview
The protein engineering market is anticipated to register a significant CAGR of 7.62% during the review period to surpass USD 3,023.29 million by 2027. Nowadays, the protein engineering market is acquiring fame because of less utilization of non-protein drugs. The consequences of protein drugs are positive in the clinical area.

Because of this, the interest in protein engineering is expanding in numerous areas. Protein engineering has an enormous degree as it can decrease the shortcoming of clinical medications. Likewise, the proficiency and viability of the medication are high.

Generally, the pervasiveness of protein engineering brings about more cardiovascular fixes. The utilization of the protein engineering device is prompting considerably more advantages in the clinical area.

The therapy of disease, immune system, and relocate dismissals are conceivable through protein engineering. Additionally, the all-around designed methods of protein in drugs are giving remarkable outcomes and conveyance. The expanding innovative work interest in the wellbeing area is the vital justification behind the popularity.

Likewise, really advertising and commercialization of the medications is one more justification for more interest. There is a mixture of protein engineering techniques and applications in the impending years.

Particularly the biotechnical drug organization holds the most extreme protein piece of the pie. The ascent of the reception of silicon model protein in this area is promoting a positive effect on the protein engineering market. It will prompt further improvement of the general market.

Segment overview
The global protein engineering market has been classified based on product, protein type, technology, and end-user.

In terms of product segment, the global market has been divided into Instruments, Consumables, and Services, and software. Based on Protein type the market has been classified into Coagulation factors, Monoclonal antibodies, Growth hormones, Vaccines, Vaccines, and Interferon.

Based on Technology type the market has been categorized into Irrational protein design and Rational protein design.
The End-user segment segregates the global protein engineering market into Academic research institutes, biopharmaceutical companies, and Contract research organizations.

Regional analysis
The region-specific analysis of the global protein engineering market is studied across Asia Pacific, North America, and Europe.

North America is set to overwhelm the market with the biggest offer. Further, the developing venture is the main consideration for a market extension. The market advancement rate will be higher for the North American region. The rising technique of extent protein engineering is driving more interest.

The Asia Pacific market is rapidly occupying in the projected timeframe. The high advancement is a direct result of more care about protein engineering. The progression in genomics is the earnest driver for the market.

Further, the advancement of proteomics is higher around here. The regulatory drives for the medicine-based market are higher. The allotments support protein engineering turning out to be more. Additionally, Europe is standing up to direct revenue for the market around here. Europe will see greater improvement during the review period.

Prominent Players
The key player of the protein engineering market is ProteoGenix, Bio-Rad Laboratories, PhyNexus, Inc, Thermo Fisher Scientific, Broker Corporation, Zymeworks, Inc, Waters Corporation, Aspira Chemical, Danaher Corporation, InvivoGen, New England Biolabs, Enantis S.R.O, New England Biolabs, Promega Corporation, and New England Biolabs.

COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries.

Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Protein supplements market : Global Analysis of Market Size, Share & Trends for 2019 – 2020 and Forecasts to 2030

Additional information

Publisher

Geography Covered

Date Published

Pages

Format

Table of Contents

TABLE OF CONTENTS 1 EXECUTIVE SUMMARY 2 MARKET INTRODUCTION 2.1 SCOPE OF THE STUDY 2.2 RESEARCH OBJECTIVE 2.3 MARKET STRUCTURE 2.4 ASSUMPTIONS & LIMITATIONS 3 RESEARCH METHODOLOGY 3.1 DATA MINING 3.2 SECONDARY RESEARCH 3.3 PRIMARY RESEARCH 3.4 BREAKDOWN OF PRIMARY RESPONDENTS 3.5 FORECASTING TECHNIQUES 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 3.6.1 BOTTOM-UP APPROACH 3.6.2 TOP-DOWN APPROACH 3.7 DATA TRIANGULATION 3.8 VALIDATION 4 MARKET DYNAMICS 4.1 OVERVIEW 4.2 DRIVERS 4.2.1 INCREASING PREVALENCE OF CHRONIC DISEASES 4.2.2 INCREASING INVESTMENTS IN SYNTHETIC BIOLOGY 4.3 RESTRAINTS 4.3.1 LACK OF TRAINED PROFESSIONALS 4.4 OPPORTUNITIES 4.4.1 EMERGING MARKETS OF PROTEIN ENGINEERING 5 MARKET FACTOR ANALYSIS 5.1 VALUE CHAIN ANALYSIS 5.1.1 R&D 5.1.2 MANUFACTURING 5.1.3 DISTRIBUTION AND SALES 5.1.4 POST-SALES MONITORING 5.2 PORTER'S FIVE FORCES MODEL 5.2.1 BARGAINING POWER OF SUPPLIERS 5.2.2 BARGAINING POWER OF BUYERS 5.2.3 THREAT OF NEW ENTRANTS 5.2.4 THREAT OF SUBSTITUTES 5.2.5 INTENSITY OF RIVALRY 5.3 IMPACT OF COVID-19 ON THE PROTEIN ENGINEERING MARKET 5.3.1 IMPACT ON DEMAND 5.3.2 IMPACT ON RESEARCH 5.3.3 IMPACT ON SUPPLY CHAIN 6 GLOBAL PROTEIN ENGINEERING MARKET, BY TYPE 6.1 OVERVIEW 6.2 INSTRUMENT 6.3 REAGENT 6.4 SERVICES & SOFTWARE 7 GLOBAL PROTEIN ENGINEERING MARKET, BY APPLICATION 7.1 OVERVIEW 7.2 FOOD & DETERGENT INDUSTRIES 7.3 ENVIRONMENTAL 7.4 MEDICAL 7.5 BIOPOLYMER PRODUCTION 7.6 NANOBIOTECHNOLOGY 8 GLOBAL PROTEIN ENGINEERING MARKET, BY METHOD 8.1 OVERVIEW 8.2 RATIONAL PROTEIN DESIGN 8.3 DIRECTED EVOLUTION 9 GLOBAL PROTEIN ENGINEERING MARKET, BY END USER 9.1 OVERVIEW 9.2 PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES 9.3 CONTRACT ENGINEERING ORGANIZATIONS 9.4 ACADEMIC RESEARCH INSTITUTES 10 GLOBAL PROTEIN ENGINEERING MARKET, BY REGION 10.1 OVERVIEW 10.2 AMERICAS 10.2.1 NORTH AMERICA 10.2.1.1 US 10.2.1.2 CANADA 10.2.2 SOUTH AMERICA 10.3 EUROPE 10.3.1 WESTERN EUROPE 10.3.1.1 GERMANY 10.3.1.2 FRANCE 10.3.1.3 UK 10.3.1.4 ITALY 10.3.1.5 SPAIN 10.3.1.6 REST OF WESTERN EUROPE 10.3.2 EASTERN EUROPE 10.4 ASIA-PACIFIC 10.4.1 JAPAN 10.4.2 CHINA 10.4.3 INDIA 10.4.4 AUSTRALIA 10.4.5 SOUTH KOREA 10.4.6 REST OF ASIA-PACIFIC 10.5 MIDDLE EAST & AFRICA 10.5.1 UAE 10.5.2 SAUDI ARABIA 10.5.3 OMAN 10.5.4 KUWAIT 10.5.5 QATAR 10.5.6 REST OF THE MIDDLE EAST & AFRICA 11 COMPETITIVE LANDSCAPE 11.1 OVERVIEW 11.2 COMPETITIVE BENCHMARKING 11.3 MAJOR GROWTH STRATEGY IN THE PROTEIN ENGINEERING MARKET 11.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE PROTEIN ENGINEERING MARKET 11.5 KEY DEVELOPMENT ANALYSIS 11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 11.6.1 PRODUCT APPROVALS AND PRODUCT LAUNCHES/PIPELINE DRUGS 11.6.2 PARTNERSHIP/COLLABORATION 11.6.3 EXPANSIONS/AGREEMENT 11.6.4 MARKETING STRATEGY 11.6.5 MERGERS & ACQUISITIONS 11.7 MAJOR PLAYERS SALES ANALYSIS 11.7.1 SALES & OPERATING INCOME 11.8 MAJOR PLAYERS R&D ANALYSIS 12 COMPANY PROFILES 12.1 THERMO FISHER SCIENTIFIC INC. 12.1.1 COMPANY OVERVIEW 12.1.2 FINANCIAL OVERVIEW 12.1.3 PRODUCTS/SERVICES OFFERED 12.1.4 KEY DEVELOPMENTS 12.1.5 SWOT ANALYSIS 12.1.6 KEY STRATEGIES 12.2 BIO-RAD LABORATORIES, INC. 12.2.1 COMPANY OVERVIEW 12.2.2 FINANCIAL OVERVIEW 12.2.3 PRODUCTS/SERVICES OFFERED 12.2.4 KEY DEVELOPMENTS 12.2.5 SWOT ANALYSIS 12.2.6 KEY STRATEGIES 12.3 GENSCRIPT 12.3.1 COMPANY OVERVIEW 12.3.2 FINANCIAL OVERVIEW 12.3.3 PRODUCTS/SERVICES OFFERED 12.3.4 KEY DEVELOPMENTS 12.3.5 SWOT ANALYSIS 12.3.6 KEY STRATEGIES 12.4 AGILENT TECHNOLOGIES, INC. 12.4.1 COMPANY OVERVIEWS 12.4.2 FINANCIAL OVERVIEW 12.4.3 PRODUCTS/SERVICES OFFERED 12.4.4 KEY DEVELOPMENTS 12.4.5 SWOT ANALYSIS 12.4.6 KEY STRATEGIES 12.5 PERKINELMER INC. 12.5.1 COMPANY OVERVIEWS 12.5.2 FINANCIAL OVERVIEW 12.5.3 PRODUCTS/SERVICES OFFERED 12.5.4 KEY DEVELOPMENTS 12.5.5 SWOT ANALYSIS 12.5.6 KEY STRATEGIES 12.6 BRUKER 12.6.1 COMPANY OVERVIEW 12.6.2 FINANCIAL OVERVIEW 12.6.3 PRODUCTS/SERVICES OFFERED 12.6.4 KEY DEVELOPMENTS 12.6.5 SWOT ANALYSIS 12.6.6 KEY STRATEGIES 12.7 WATERS CORPORATION 12.7.1 COMPANY OVERVIEW 12.7.2 FINANCIAL OVERVIEW 12.7.3 PRODUCTS/SERVICES OFFERED 12.7.4 KEY DEVELOPMENTS 12.7.5 SWOT ANALYSIS 12.7.6 KEY STRATEGIES 12.8 MERCK KGAA 12.8.1 COMPANY OVERVIEW 12.8.2 FINANCIAL OVERVIEW 12.8.3 PRODUCTS/SERVICES OFFERED 12.8.4 KEY DEVELOPMENTS 12.8.5 SWOT ANALYSIS 12.8.6 KEY STRATEGIES 12.9 PROMEGA CORPORATION 12.9.1 COMPANY OVERVIEWS 12.9.2 FINANCIAL OVERVIEW 12.9.3 PRODUCTS/SERVICES OFFERED 12.9.4 KEY DEVELOPMENTS 12.9.5 SWOT ANALYSIS 12.9.6 KEY STRATEGIES 12.10 DANAHER CORPORATION (AB-SCIEX) 12.10.1 COMPANY OVERVIEW 12.10.2 FINANCIAL OVERVIEW 12.10.3 PRODUCTS/SERVICES OFFERED 12.10.4 KEY DEVELOPMENTS 12.10.5 SWOT ANALYSIS 12.10.6 KEY STRATEGIES 13 APPENDIX 13.1 REFERENCES 13.2 RELATED REPORTS

Related products